AETC ShareSpot: New HIV Meds Updates

AETC ShareSpot: New HIV Meds Updates

Friday, April 20, 2018
TARGET Center

From AETC ShareSpot - Six HIV medication summary updates are available on the AETC ShareSpot with updates from CROI 2018. The April 11 updates were prepared by Susa Coffey, MD, medical editor of the AETC NCRC and include:

  • Bictegravir Approved for Initial ART, in Combination with TAF/FTC
  • Bictegravir /TAF/FTC in Women
  • Immediate ART Initiation Improves Time to Viral Suppression
  • Darunavir/Cobicistat/FTC/TAF Single-Pill Combination in Treatment-Experienced Patients: EMERALD Study 
  • Ibalizumab Approved for Persons with Multidrug-Resistant HIV
  • Naltrexone Improves Virologic Suppression 

Subscribe to receive AETC mailings.